Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Dec 09, 2022	Landry Robert E EVP Finance CFO Trans History: 465	EVP Finance CFO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	492	$753.28	28,991
Dec 09, 2022	LAROSA JOSEPH J EVP General Counsel and Secret Trans History: 181	EVP General Counsel and Secret	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	492	$753.28	20,358
Dec 09, 2022	McCourt Marion EVP Commercial Trans History: 141	EVP Commercial	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	274	$753.28	19,370
Dec 09, 2022	MURPHY ANDREW J EVP Research Trans History: 222	EVP Research	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	492	$753.28	56,618
Dec 09, 2022	STAHL NEIL EVP Research and Development Trans History: 660	EVP Research and Development	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	466	$753.28	51,999
Dec 09, 2022	VAGELOS P ROY Director Trans History: 742	Director	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	57	$753.28	322,432
Dec 09, 2022	Van Plew Daniel P EVP & General Mgr, Industrial Trans History: 359	EVP & General Mgr, Industrial	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	492	$753.28	30,086
Dec 12, 2022	Landry Robert E EVP Finance CFO Trans History: 465	EVP Finance CFO	Form 4	Other acquisition or disposition	--	--	250
Dec 12, 2022	McCourt Marion EVP Commercial Trans History: 141	EVP Commercial	Form 4	Open market or private sale of non-derivative or derivative security	264	$730.17	19,106
Dec 13, 2022	Fenimore Christopher R. SVP Controller Trans History: 306	SVP Controller	Form 4	Other acquisition or disposition	--	--	1,779

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media